Fermentation parameters such as pH, temperature, oxygen, time, mixing, light, and sterility critically impact microbial performance, and AI-enabled analytics help reveal how these variables relate to yield and stability during scale-up.

Biological discovery differs from traditional chemistry due to living organisms and complex interactions, so AI aids but cannot replace downstream development like characterization, fermentation optimization, and field testing.

A broader development chain is forming: AI and bioinformatics identify candidates, automated screening assesses alternatives, fermentation scales production, formulation ensures stability, agronomic trials prove efficacy, and regulatory processes authorize market entry, all hinging on data quality and end-to-end integration.

Bayer Crop Science is accelerating product development through field trials, digital tools, and AI, with farmer input playing a critical role in guiding the process.

In the United States and Latin America, regulatory considerations shape speed-to-market for biologicals, with the EPA requiring regulatory dossiers even as discovery speeds up.

Faster discovery shifts the bottleneck to manufacturing scale-up, stability, and field performance, underscoring the need for robust data and processes to turn lab activity into commercial products.

Only a subset of ideas reach the farm; Bayer tests hundreds of thousands of genetic combinations and tens of thousands of chemistries and proteins, with failures guiding next-generation designs.

Corteva demonstrated AI modeling on thousands of potential crop-protection molecules in weeks, predicting biomolecule diversity and streamlining fermentation for biologicals, showing practical impact of AI on early discovery.

AI is reshaping R&D by enabling faster digital discovery, but the challenge remains turning discoveries into stable, scalable, registrable, field-proven products that deliver consistent farmer-level performance.

The next decade could bring faster innovation, including genome editing and Bayer’s Precion corn system that combines genetics with digital insights and in-season support.

Field testing remains essential to validate innovations under real-world farmer conditions, despite predictive technology.

Brazil emerged as a leading testing ground with a record 162 bioinput registrations in 2025, signaling rapid market expansion and the need for scalable development, formulation, and regulatory data management.